Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex versus neostigmine reversal and ventilatory control in healthy volunteers
2015-005222-19Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2016
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of Sugammadex and neostigmine (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Ventilatory response to hypoxic challenge and Ventilatory response to hypercapnic challenge under hyperoxic conditions. Started Jul 2016; status: active.
02
Drugs
Sugammadexneostigmine
Beyond the preview
Go deeper on 2015-005222-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005222-19.